SAVINI, AGNESE
 Distribuzione geografica
Continente #
NA - Nord America 763
EU - Europa 375
AS - Asia 164
AF - Africa 35
SA - Sud America 26
OC - Oceania 1
Totale 1.364
Nazione #
US - Stati Uniti d'America 763
IT - Italia 80
SE - Svezia 68
UA - Ucraina 56
SG - Singapore 51
IE - Irlanda 41
RU - Federazione Russa 41
CN - Cina 40
DE - Germania 30
HK - Hong Kong 30
CI - Costa d'Avorio 26
TR - Turchia 26
BR - Brasile 24
DK - Danimarca 19
FI - Finlandia 15
FR - Francia 11
GB - Regno Unito 10
KR - Corea 10
MA - Marocco 8
IN - India 3
BE - Belgio 2
AR - Argentina 1
AU - Australia 1
AZ - Azerbaigian 1
JP - Giappone 1
LB - Libano 1
NL - Olanda 1
PE - Perù 1
PL - Polonia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 1.364
Città #
Chandler 132
Ashburn 71
Jacksonville 70
Boardman 45
New York 45
Fairfield 43
Dublin 40
Wilmington 36
Hong Kong 30
Singapore 30
Woodbridge 29
Seattle 27
Abidjan 26
Cambridge 20
Houston 19
Ann Arbor 17
Centro 17
Lawrence 16
Princeton 16
Turin 16
San Mateo 14
Des Moines 11
Beijing 9
Washington 9
Los Angeles 7
Guangzhou 5
Helsinki 5
San Diego 5
The Dalles 5
Moscow 4
Munich 4
Cantu 3
Falls Church 3
Norwalk 3
Shanghai 3
Brussels 2
Caserta 2
Guarulhos 2
Marche 2
Pune 2
Recanati 2
Rio de Janeiro 2
Salvador 2
Segrate 2
São Paulo 2
Turku 2
Wuhan 2
Ankara 1
Arequipa 1
Bagé 1
Baku 1
Belo Horizonte 1
Brisbane 1
Cabo Frio 1
Caraguatatuba 1
Catalão 1
Chennai 1
Chicago 1
Chiswick 1
Cincinnati 1
Civitanova Marche 1
Cupra Marittima 1
Dallas 1
Dangan 1
Divinópolis 1
Duque de Caxias 1
Fayetteville 1
Friesland 1
Handan 1
Iporá 1
Jiaxing 1
Kilburn 1
Korba 1
Lagoa Santa 1
London 1
Manaus 1
Mestre 1
Mondolfo 1
Montegiorgio 1
Osimo 1
Phoenix 1
Pontal 1
Porto 1
Porto Alegre 1
Prescot 1
Qingdao 1
Redwood City 1
Rio Branco 1
Salta 1
San Costanzo 1
Shaoxing 1
Sioux Falls 1
Southwark 1
São José 1
Tampa 1
Tashkent 1
Tolentino 1
Ubá 1
Warsaw 1
Wuxi 1
Totale 912
Nome #
Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review. 123
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 117
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients 100
Role of DCE-MR imaging of the breast in predicting breast cancer subtypes: where are we going? 94
Managing hyponatremia in lung cancer: latest evidence and clinical implications 94
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 90
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 89
Correlation of Stomatitis and Cutaneous Toxicity With Clinical Outcome in Patients With Metastatic Renal-Cell Carcinoma Treated With Everolimus 86
Long‑responders to anti‑HER2 therapies: A case report and review of the literature 84
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 83
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 82
IMPACT OF VEGF, VEGFR, PDGFR, HIF AND ERCC1 GENE POLYMORPHISMS ON THYMIC MALIGNANCIES OUTCOME 80
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 80
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 77
The impact of lifestyle interventions in high‐risk early breast cancer patients: A modeling approach from a single institution experience 71
Treatment of advanced small cell lung cancer 59
Totale 1.409
Categoria #
all - tutte 7.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 0 0 0 0 0 0 0 0 0 0 9 21
2020/2021249 17 22 49 1 27 17 14 14 24 24 24 16
2021/2022123 8 17 3 5 1 15 7 5 9 16 11 26
2022/2023324 22 45 21 37 19 45 0 11 79 1 36 8
2023/2024201 24 4 17 12 29 72 1 12 2 6 1 21
2024/2025262 56 28 8 4 22 10 20 7 58 22 27 0
Totale 1.409